Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Aug;3(4):173-82.
doi: 10.1177/1756287211418722.

Surgery for high-risk localized prostate cancer

Affiliations

Surgery for high-risk localized prostate cancer

Jan Schmitges et al. Ther Adv Urol. 2011 Aug.

Abstract

Treatment of men with high-risk prostate cancer (PCa) remains challenging for urologists. The complex natural history of high-risk PCa and the lack of specific and accurate definitions for high-risk disease impede treatment decision making. Historically, surgery in this patient group has been avoided based on the perception of ostensibly higher complication rates associated with inferior functional and oncological outcomes. To date, no randomized data comparing different therapy approaches have been made available. Several investigators have reported that continence rates in patients after radical prostatectomy (RP) for high-risk disease seem to be unaffected. Similarly, in a large proportion of these men, a nerve-sparing procedure can be performed without a significant negative impact on surgical margin rates and with comparable potency results. Moreover, extended pelvic lymph node dissection (EPLND) contributes to accurate pathological staging with a marginal effect on perioperative morbidity. With regards to the benefits of RP on local recurrence and cure rates, realistic expectations regarding the success of RP alone or in the context of a multimodal approach should be provided during patient counseling.

Keywords: high-risk prostate cancer; perioperative complications; prostatectomy; urinary incontinence.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
The probability of biochemical recurrence (BCR)-free survival rates in a large European and North American cohort of patients with high-risk prostate cancer (A). The effect of clinical stage (B), biopsy Gleason sum (C), stratified pretreatment serum prostate-specific antigen (PSA) levels (D), D’Amico risk grouping (E) on BCR-free survival rates are depicted. Graphical comparison of the BCR-free survival rates according to the four high-risk definitions (F) and the effect of the cumulative number of risk factors (G) are illustrated. (Reprinted with permission from Walz et al. [2011] Copyright © [2011][Wiley-Blackwell] [BJUI]. Access at: http://onlinelibrary.wiley.com/doi/10.1111/j.1464-410X.2010.09594.x/abstract;jsessionid=33AE69ED23E0C02B29DB9B14EB3A444E.d02t04.).

References

    1. Agarwal P.K., Sammon J., Bhandari A., Dabaja A., Diaz M., Dusik-Fenton S., et al. (2011) Safety profile of robot-assisted radical prostatectomy: a standardized report of complications in 3317 patients. Eur Urol in press - PubMed
    1. Allaf M.E., Palapattu G.S., Trock B.J., Carter H.B., Walsh P.C. (2004) Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer. J Urol 172: 1840–1844 - PubMed
    1. American Joint Committee on Cancer (2002) AJCC Staging Manual 6th edn Springer: New York
    1. Bader P., Burkhard F.C., Markwalder R., Studer U.E. (2003) Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? J Urol 169: 849–854 - PubMed
    1. Bastian P.J., Gonzalgo M.L., Aronson W.J., Terris M.K., Kane C.J., Amling C.L., et al. (2006) Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10. Cancer 107: 1265–1272 - PubMed

LinkOut - more resources